Literature DB >> 23391484

In vitro toxicological characterization of perfluorinated carboxylic acids with different carbon chain lengths.

Thorsten Buhrke1, Anja Kibellus, Alfonso Lampen.   

Abstract

Perfluorooctanoic acid (PFOA) is in use for the production of fluoropolymers (PFT). Due to its toxic properties it was proposed to replace the substance in its industrial applications by homologous compounds with shorter carbon chain length that were supposed to be less toxic compared to PFOA, however, the smaller PFOA homologs are poorly characterized so far. In this study we have conducted a comparative analysis of the toxicity of perfluorinated carboxylic acids (PFCA) with a carbon chain length ranging from four to twelve carbon atoms. By using the human hepatocarcinoma cell line HepG2 as an in vitro model for human hepatocytes we could show a positive correlation between the carbon chain length of the respective PFCA and its cytotoxicity. There was, however, no indication of an apoptotic mechanism for cytotoxicity. All PFCA under investigation were negative in two independent genotoxicity assays. As PFOA, being a well-known peroxisome proliferator, the other PFCA tested in this study were also shown to activate human peroxisome proliferator-activated receptor alpha (PPARα) with PFOA having the highest potential of PPARα activation. Moreover, the compounds showed weak potential to activate PPARγ and hardly activated PPARδ. Taken together, the in vitro study revealed that PFCA with a shorter carbon chain length seem to be less toxic than PFOA.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23391484     DOI: 10.1016/j.toxlet.2013.01.025

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  23 in total

1.  Perfluorooctanoic acid activates multiple nuclear receptor pathways and skews expression of genes regulating cholesterol homeostasis in liver of humanized PPARα mice fed an American diet.

Authors:  J J Schlezinger; H Puckett; J Oliver; G Nielsen; W Heiger-Bernays; T F Webster
Journal:  Toxicol Appl Pharmacol       Date:  2020-08-19       Impact factor: 4.219

Review 2.  Impact of perfluorochemicals on human health and reproduction: a male's perspective.

Authors:  C Foresta; S Tescari; A Di Nisio
Journal:  J Endocrinol Invest       Date:  2017-11-17       Impact factor: 4.256

3.  Effects of prenatal perfluoroalkyl acid exposure on cord blood IGF2/H19 methylation and ponderal index: The Hokkaido Study.

Authors:  Sachiko Kobayashi; Kaoru Azumi; Houman Goudarzi; Atsuko Araki; Chihiro Miyashita; Sumitaka Kobayashi; Sachiko Itoh; Seiko Sasaki; Mayumi Ishizuka; Hiroyuki Nakazawa; Tamiko Ikeno; Reiko Kishi
Journal:  J Expo Sci Environ Epidemiol       Date:  2016-08-24       Impact factor: 5.563

4.  Per- and polyfluoroalkyl substances impact human spermatogenesis in a stem-cell-derived model.

Authors:  Alyse N Steves; Adam Turry; Brittany Gill; Danielle Clarkson-Townsend; Joshua M Bradner; Ian Bachli; W Michael Caudle; Gary W Miller; Anthony W S Chan; Charles A Easley
Journal:  Syst Biol Reprod Med       Date:  2018-06-18       Impact factor: 3.061

5.  Per- and polyfluoroalkyl substances target and alter human prostate stem-progenitor cells.

Authors:  Wen-Yang Hu; Ranli Lu; Dan Ping Hu; Ozan Berk Imir; Qianying Zuo; Dan Moline; Parivash Afradiasbagharani; Lifeng Liu; Scott Lowe; Lynn Birch; Donald J Vander Griend; Zeynep Madak-Erdogan; Gail S Prins
Journal:  Biochem Pharmacol       Date:  2021-12-27       Impact factor: 5.858

6.  Predicting the effects of per- and polyfluoroalkyl substance mixtures on peroxisome proliferator-activated receptor alpha activity in vitro.

Authors:  Greylin Nielsen; Wendy J Heiger-Bernays; Jennifer J Schlezinger; Thomas F Webster
Journal:  Toxicology       Date:  2021-11-04       Impact factor: 4.221

7.  In vitro activity of a panel of per- and polyfluoroalkyl substances (PFAS), fatty acids, and pharmaceuticals in peroxisome proliferator-activated receptor (PPAR) alpha, PPAR gamma, and estrogen receptor assays.

Authors:  Nicola Evans; Justin M Conley; Mary Cardon; Phillip Hartig; Elizabeth Medlock-Kakaley; L Earl Gray
Journal:  Toxicol Appl Pharmacol       Date:  2022-06-22       Impact factor: 4.460

8.  C6-Perfluorinated Compounds: The New Greaseproofing Agents in Food Packaging.

Authors:  Penelope A Rice
Journal:  Curr Environ Health Rep       Date:  2015-03

9.  Association between gestational PFAS exposure and Children's adiposity in a diverse population.

Authors:  Michael S Bloom; Sarah Commodore; Pamela L Ferguson; Brian Neelon; John L Pearce; Anna Baumer; Roger B Newman; William Grobman; Alan Tita; James Roberts; Daniel Skupski; Kristy Palomares; Michael Nageotte; Kurunthachalam Kannan; Cuilin Zhang; Ronald Wapner; John E Vena; Kelly J Hunt
Journal:  Environ Res       Date:  2021-07-31       Impact factor: 6.498

10.  Perfluorooctanoic acid induces liver and serum dyslipidemia in humanized PPARα mice fed an American diet.

Authors:  J J Schlezinger; T Hyötyläinen; T Sinioja; C Boston; H Puckett; J Oliver; W Heiger-Bernays; T F Webster
Journal:  Toxicol Appl Pharmacol       Date:  2021-07-10       Impact factor: 4.460

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.